Bacterial lipase and high-fat diets in canine exocrine pancreatic insufficiency: a new therapy of steatorrhea?

Gastroenterology
A SuzukiE P DiMagno

Abstract

Nutrients and properties of lipases affect survival of lipolytic activity during aboral gastrointestinal transit. Whether different doses and formulations of bacterial lipase and diets affect steatorrhea was tested in pancreatic-insufficient dogs. A dose of 0-600,000 IU of powdered and 135,000 and 300,000 IU of liquid bacterial lipase was given with a standard meal to 5 dogs with ligated pancreatic ducts. In 4 dogs, 0 or 300,000 IU (normal 6-hour postprandial amount) of powder bacterial lipase was also given with five meals containing 850 kcal with different nutrient caloric densities (mixture design). Coefficients of fat absorption during 72-hour fecal balance studies were used to assess treatments. With the standard meal, powder bacterial lipase reduced steatorrhea in a dose-dependent manner (P = 0.03), and 135,000 and 300,000 IU of the liquid form decreased steatorrhea more than powder bacterial lipase (P = 0.017 and 0.057, respectively). Coefficients of fat absorption with 300,000 IU of powder bacterial lipase correlated (r2 = 0.79; P < 0.001) with increasing proportions of fat calories in diets. Liquid bacterial lipase decreases steatorrhea more than powder, and 300,000 IU of powder bacterial lipase ingested with high-fat ...Continue Reading

Citations

Jul 23, 1999·Annals of the New York Academy of Sciences·P Ghaneh, J P Neoptolemos
Aug 27, 2009·Therapeutics and Clinical Risk Management·Devi Mukkai KrishnamurtyDana K Andersen
Jul 27, 2012·Therapeutic Delivery·Jean-Claude Bakala N'GomaFrédéric Carrière
Jun 1, 2010·Best Practice & Research. Clinical Gastroenterology·E C M SikkensM J Bruno
Mar 20, 2009·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Sofia RengmanStefan Pierzynowski
Feb 3, 2007·Biochimica Et Biophysica Acta·Ahmed AloulouFrédéric Carrière
Nov 28, 2013·Journal of Gastroenterology and Hepatology·Supot Pongprasobchai
May 9, 2006·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·R MeierUNKNOWN ESPEN (European Society for Parenteral and Enteral Nutrition)
Feb 13, 2004·The Journal of Veterinary Medical Science·Giuseppe PiccioneGiovanni Caola
Apr 15, 2016·Pancreas·Eugene P DiMagno, Matthew J DiMagno
May 26, 2001·The American Journal of Gastroenterology·J P ChungJ K Kang
Apr 11, 2009·World Journal of Gastroenterology : WJG·Raffaele Pezzilli
Mar 29, 2001·Current Gastroenterology Reports·P LayerP G Lankisch
Sep 5, 2003·Current Treatment Options in Gastroenterology·Jutta Keller, Peter Layer
Dec 25, 2002·Pancreas·Peter Layer, Jutta Keller
Jan 23, 1999·Journal of Clinical Gastroenterology·P Layer, J Keller
Oct 6, 1999·Journal of Clinical Gastroenterology·M V ApteJ S Wilson
Aug 13, 2002·European Journal of Gastroenterology & Hepatology·Javier P GisbertJosé María Pajares
Sep 28, 2002·European Journal of Gastroenterology & Hepatology·Asif Khalid, David C Whitcomb
Jun 18, 2017·Journal of Nutritional Science·Cecilia VillaverdeJennifer A Larsen
Dec 1, 2000·Scandinavian Journal of Gastroenterology·J S ScolapioM Lankisch
Oct 29, 2000·American Journal of Physiology. Gastrointestinal and Liver Physiology·D G KuhelD Y Hui
Sep 10, 2011·Deutsches Ärzteblatt International·Joachim Mössner, Volker Keim
Sep 30, 1999·Gastroenterology Clinics of North America·J S ScolapioA Ukleja
Aug 3, 2001·Primary Care·S Tabrez, I M Roberts

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.